Corona Remedies shares pop after impressive stock market debut
Corona Remedies made a strong entrance on the stock market, with shares jumping over 3% on listing day.
The stock opened at ₹1,470 on NSE—a solid 38% above its issue price of ₹1,062—and hit a high of ₹1,499 during the day.
IPO buzz and investor response
The company's IPO, worth ₹655 crore and open from December 8 to 10, was a big hit.
It was oversubscribed 144.5 times overall—QIBs led the charge (nearly 294 times), followed by non-institutional investors (more than 220 times) and retail investors (over 30 times).
What does Corona Remedies actually do?
Corona Remedies is all about healthcare—they run 71 brands across areas like women's health, heart and diabetes care, pain relief, urology, and chronic conditions.
With more than 2,600 medical reps in 22 states, they've built quite the network.
In FY25 alone, their revenue jumped 18% to ₹1,202 crore and profits surged by 65% to ₹149 crore.